Vanguard Group Inc. Buys 557,329 Shares of DENTSPLY SIRONA Inc. $XRAY

Vanguard Group Inc. boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 2.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,740,589 shares of the medical instruments supplier’s stock after purchasing an additional 557,329 shares during the quarter. Vanguard Group Inc. owned approximately 10.41% of DENTSPLY SIRONA worth $309,864,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in XRAY. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $26,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in DENTSPLY SIRONA in the 1st quarter worth approximately $25,000. True Wealth Design LLC grew its position in shares of DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 1,950 shares in the last quarter. Quarry LP increased its holdings in shares of DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 780 shares during the period. Finally, Allworth Financial LP raised its position in shares of DENTSPLY SIRONA by 175.8% in the first quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier’s stock worth $54,000 after buying an additional 2,517 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several research analyst reports. Barrington Research set a $18.00 price objective on DENTSPLY SIRONA and gave the company an “outperform” rating in a research note on Friday, August 8th. Stifel Nicolaus lowered their price target on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating on the stock in a report on Friday, August 8th. Piper Sandler cut their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, April 30th. Wells Fargo & Company decreased their price objective on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Friday, August 8th. Finally, UBS Group lowered their target price on shares of DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Twelve equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $18.64.

DENTSPLY SIRONA Trading Down 0.1%

Shares of XRAY opened at $13.85 on Monday. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of -2.92, a PEG ratio of 0.86 and a beta of 0.94. The firm has a 50 day moving average price of $15.46 and a 200-day moving average price of $15.65. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. The firm had revenue of $936.00 million for the quarter, compared to the consensus estimate of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The company’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.49 earnings per share. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.